鼻咽癌
辐射敏感性
癌症研究
基因敲除
细胞凋亡
细胞培养
流式细胞术
生物
转染
下调和上调
细胞生长
医学
分子生物学
放射治疗
内科学
基因
遗传学
作者
Yang Liu,Qinshan Li,Huiling Liang,Miaomiao Xiang,Dongdong Tang,Mei Huang,Yixi Tao,Min Ren,Ming Zhao,Jishi Wang,Liping Shu,Zhixu He,Feiqing Wang,Yanju Li
标识
DOI:10.1177/1533033820940424
摘要
Background/Aims: Nasopharyngeal carcinoma is a common head and neck cancer in South China and Southeast Asia. Radiotherapy is the standard treatment for nasopharyngeal carcinoma. Accumulating evidence showed that the expression of miR-34a was abnormal in nasopharyngeal carcinoma. Here, this study investigates the effect of miR-34a on radiosensitivity of nasopharyngeal carcinoma cells and explored the underlying mechanisms. Methods: Reverse transcription quantitative polymerase chain reaction was used to analyze the expression of miR-34a in nasopharyngeal carcinoma cell lines and NP69 cells. The effect of miR-34a on radiosensitivity of nasopharyngeal carcinoma (CNE-1 cells) was evaluated by Cell Counting Kit-8, flow cytometry, and Transwell migration assays following transfection with miR-34a mimic. Luciferase reporter assay was used to assess the target genes of miR-34a. Results: In this study, it revealed that miR-34a was downregulated, while silent information regulator 1 was upregulated in nasopharyngeal carcinoma cell lines. The overexpression of miR-34a enhanced radiation-induced proliferation and migration inhibition and apoptosis in CNE-1 cells. Bioinformatics, Luciferase reporter, reverse transcription quantitative polymerase chain reaction, and Western blotting assays indicated that silent information regulator 1 is a direct target of miR-34a in nasopharyngeal carcinoma cells. Knockdown of silent information regulator 1 enhanced radiosensitivity of nasopharyngeal carcinoma cells as evidenced by increasing proliferation and migration inhibition and apoptosis after radiation exposure. Conclusion: In summary, our results indicated that the overexpression of miR-34a enhanced radiosensitivity of nasopharyngeal carcinoma cells by targeting silent information regulator 1. Further studies are warranted to investigate the potential use of miR-34a in the clinical management and treatment prediction of patients with nasopharyngeal carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI